Xtant Medical Holdings, Inc. XTNT
0.38
0.00
0.00%
as of 25 Sep
- Market cap
- $52.9M
- P/E
- 0.0×
Follow XTNT
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
3.65% | 10.59% | 3.95% | (25.16%) | |
| 1.71% | 5.29% | 2.10% | (12.16%) | ||
ROIC |
5.79% | 7.71% | 4.23% | (12.43%) | |
Return on Tangible Assets |
3.32% | 9.05% | 3.67% | (27.60%) | |
Average Days of Receivables |
69.98 | 48.52 | 51.44 | 64.70 | |
Free Cash Flow per Share |
0.04 | 0.07 | 0.06 | 0.00 | |
Free Cash Flow |
5.48 | 10.40 | 8.00 | (0.46) | |
Capital Expenditures |
(2.35) | (2.15) | (1.15) | (1.03) | |
Piotroski F-Score |
8.00 | 8.00 | 8.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
8.72% | 13.39% | 12.54% | 0.78% | |
Accounts Receivable Turnover |
5.78 | 6.96 | 6.00 | 4.72 | |
Accounts Payable Turnover |
6.67 | 8.44 | 7.28 | 6.65 | |
Inventory Turnover |
1.22 | 1.44 | 1.30 | 1.21 | |
Average Days of Payables |
49.51 | 28.26 | 43.61 | 50.50 | |
Days of Inventory on Hand |
294.04 | 222.46 | 253.49 | 273.15 | |
Tax Rate |
(0.22) | (0.29) | (0.53) | 0.21 | |
Research and Development Expense of Revenue |
1.63% | 1.57% | 1.72% | 2.03% | |
Selling, General and Administrative Expense of Revenue |
55.63% | 55.92% | 57.92% | 62.38% | |
Share Based Compensation of Revenue |
2.26% | 2.16% | 2.36% | 2.73% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.47 | 2.52 | 5.01 | (0.05) | |
Depreciation/Fixed assets |
0.45 | 0.84 | 0.80 | 0.73 | |
Capex/Depreciation |
(0.52) | (0.41) | (0.25) | (0.26) | |
Revenue per Share |
0.95 | 0.96 | 0.87 | 0.78 | |
Operating CF per Share |
0.06 | 0.09 | 0.07 | 0.00 | |
Capex per Share |
(0.02) | (0.02) | (0.01) | (0.01) | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 | |
Net Profit Margin |
1.32% | 3.71% | 1.50% | (10.17%) |
Columns are period end dates